Trevena
| Region | Nordamerika |
| ISIN | US89532E1091 |
| Sektor | Biotechnologie |
| Website | http://www.trevena.com/ |
At Trevena, our mission is to deliver innovative solutions to patients and healthcare providers confronting serious medical conditions. Our history is rooted in strong science – Trevena was founded to translate Nobel Prize-winning research into a new generation of groundbreaking medicines. Our novel approach to drug discovery has established us as pioneers in acute care medicine.
| Titel | Datum |
|---|---|
| Trevena (TRVN) to Present Oliceridine for Management of Moderate to Severe Acute Pain at FDA Panel Meeting on October 11 | vor 13 Tagen |
| Trevena Inc.: Trevena to Present at the 20th Annual Rodman & Renshaw Global Investment Conference | vor 24 Tagen |
| TREVENA INC - 10-Q, Quaterly Report | vor ungefähr 2 Monaten |
| TREVENA INC - 8-K, Current Report | vor ungefähr 2 Monaten |
| Your Daily Pharma Scoop: Gemphire Zooms, Trevena Succeeds, Arsanis Falters | vor 3 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| TrackX Holdings (1 Artikel) | |
| The Priceline Group (2 Artikel) | |
| United Internet (1 Artikel) | |
| Vapiano (2 Artikel) | |
| Alle anzeigen | |